ORCA Therapeutics Competitors and Similar CompaniesClear all
ORCA Therapeutics's competitors and similar companies include Clovis Oncology, Deciphera Pharmaceuticals and PharmaEssentia.
 ORCA Therapeutics ORCA Therapeutics is a biopharmaceutical company designing and developing immunotherapies for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA). |  Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. | |
Founding Date | Founding Date 2005 | Founding Date 2009 | Founding Date 2003 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations 's-Hertogenbosch, NL HQ Amsterdam, NL Nijmegen, NL | Locations Waltham, US HQ Lawrence, US | Locations Taipei, TW HQ Shinjuku City, JP Burlington, US | |
Employees | Employees 6 | Employees 4843% increase | Employees 35037% increase | Employees 4897% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.6 m | Valuation ($) 2.2 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) NT$15.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $3.7m (FY, 2023) | Cost of goods NT$1.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $159.6m (FY, 2023) | Gross profit NT$14.4b (FY, 2025) |
Net income | Net income N/A | Net income ($264.5m) (FY, 2021) | Net income ($194.9m) (FY, 2023) | Net income NT$5b (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 1.7m | Total funding raised $ 357m | Total funding raised $ 714m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Clovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View companyDeciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View companyPharmaEssentia
HQ
Taipei, TW
Employees
489↑ 7% increase
PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
View company